Canada Markets closed
  • S&P/TSX

    21,637.54
    -15.48 (-0.07%)
     
  • S&P 500

    4,704.54
    +15.87 (+0.34%)
     
  • DOW

    35,870.95
    -60.10 (-0.17%)
     
  • CAD/USD

    0.7936
    -0.0001 (-0.0095%)
     
  • BTC-CAD

    73,092.30
    +3,730.79 (+5.38%)
     
  • CMC Crypto 200

    1,402.14
    -65.80 (-4.48%)
     
  • GOLD FUTURES

    1,861.20
    -0.20 (-0.01%)
     
  • RUSSELL 2000

    2,363.59
    -13.42 (-0.56%)
     
  • 10-Yr Bond

    1.5890
    -0.0150 (-0.94%)
     
  • NASDAQ futures

    16,494.75
    +13.50 (+0.08%)
     
  • VOLATILITY

    17.59
    +0.48 (+2.81%)
     
  • FTSE

    7,255.96
    -35.24 (-0.48%)
     
  • NIKKEI 225

    29,683.09
    +84.43 (+0.29%)
     
  • CAD/EUR

    0.6979
    +0.0004 (+0.06%)
     

Global Genomic Medicine Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2016-2026 Segmented By Application, By End User, By Region

·6 min read

This report is 90% complete and will include the latest impact analysis of Covid-19 along with updated quarterly market data for the year 2021 (estimated). This report will be delivered within three working days post order confirmation.

New York, Oct. 22, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Genomic Medicine Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2016-2026 Segmented By Application, By End User, By Region" - https://www.reportlinker.com/p06177434/?utm_source=GNW


Global Genomic Medicine Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2016-2026
Segmented By Application (Oncology, Cardiology, Endocrinology, Rare Genetic Disorders, Others), By End User (Hospitals & Clinics, Academic & Research Institutes, Others), By Region


Global genomic medicine market is expected to show robust growth with an impressive CAGR in the forecast period, 2016-2026 on the account of rising inclination for personalized medicine.The market is also subjected to the anticipated growth on the back of rising interest in the biomarkers identification for therapy, diagnosis, and prognosis for personalized medicine development.

These methods provide more effectiveness and increase the efficiency for pharmaceuticals and thus drive the future growth of the global genomic medicine market in the upcoming five years.Moreover, advancing technology and the possibility of the extended research for the identification and monitoring of different biomarkers that can be used for pharmacogenomics as well, which also substantiates the growth of the global genomic medicine market in the next five years.

Moreover, the increasing research and advancing pharma industry is aiding the growth of the global genomic medicine market in the future five years.Additionally, rising government initiatives, personal investments and increased applications of the genomic studies in the healthcare sector are also supporting the growth of the global genomic medicine market in the future five years.

Although, lack of trained technicians, slower FDA approvals, and prolonged processes of the clinical trials may put a mild restraint on the growth of the global genomic medicine market.
Genomic medicines, also known as personal medicine, are the pharmaceutical drugs that are specifically designed with the genomic information from the DNA, and protein profiling and their functionality meanwhile understanding their interaction with the human health. These medicines have the ability to provide the details of typical biological information of individuals and thereby using the information to design the respective patient’s treatment processes and pharmaceutical drugs.
The global genomic medicine market is segmented by application, end user, competitive landscape, and regional distribution.Based on application, the market is further fragmented into oncology, cardiology, endocrinology, rare genetic disorders, and others.

Oncology sub-segment is anticipated to hold the largest revenue shares of the market and dominate the market segment on the account of rapidly increasing instances of cancer and rising number of cancer patients.Various genomic studies are carried out for the diagnosis, analysis, and prognosis along with the treatment of the cancer cells.

Genomic medicines are specialized for cancer patients and its utilization is increasing, thereby supporting the growth of the global genomic medicine market in the upcoming five years.
Companies holding the major shares of the global genomic medicine market are Genome Medical, Inc., BioMed Central Ltd, Aevi Genomic Medicine, Inc., Congenica Ltd., Deep Genomics, Editas Medicine, Inc., Cleveland Clinic, among others. Market players are actively involved in the research and technological development in the product developments. The advanced technology has made it possible for the industry to provide excellent services through genomic medicine. Further advancement would aid the market value and brand establishment in the future five years. New market players may focus on the research and development to provide options that satisfy the consumer demand as well as benefits the market players in building their brand value. Other competitive strategies include mergers & acquisitions and new product developments.

Years considered for this report:

Historical Years: 2016 – 2019
Base Year: 2020
Estimated Year: 2021
Forecast Period: 2022 – 2026

Objective of the Study:

• To analyze the historical growth of the market size of global genomic medicine market from 2016 to 2019.
• To estimate and forecast the market size of global genomic medicine market from 2020 to 2026 and growth rate until 2026.
• To classify and forecast global genomic medicine market based on application, end user, competitional landscape, and regional distribution.
• To identify dominant region or segment in the global genomic medicine market.
• To identify drivers and challenges for global genomic medicine market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global genomic medicine market.
• To identify and analyze the profile of leading players operating in global genomic medicine market.
• To identify key sustainable strategies adopted by market players in global genomic medicine market.
The analyst performed both primary as well as exhaustive secondary research for this study.Initially, the analyst sourced a list of manufacturers, suppliers, and distributors across the country.

Subsequently, the analyst conducted primary research surveys with the identified companies.While interviewing, the respondents were also enquired about their competitors.

Through this technique, the analyst could include the manufactures and service providers which could not be identified due to the limitations of secondary research. The analyst examined the manufactures, distribution channels and presence of all major players across the country.
The analyst calculated the market size of global genomic medicine market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. The analyst sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size.

Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by the analyst.

Key Target Audience:

• Manufacturers, service providers, end users, and other stakeholders
• Distributors and suppliers of products & services and other stakeholders
• Organizations, forums, and alliances related to genomic medicine
• Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, service providers, suppliers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global genomic medicine market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
• Genomic Medicine Market, By Application:
o Oncology
o Cardiology
o Endocrinology
o Rare Genetic Disorders
o Others
• Genomic Medicine Market, By End User:
o Hospitals & Clinics
o Academic & Research Institutes
o Others
• Genomic Medicine Market, By Region:
o North America
United States
Canada
Mexico
o Europe
Germany
France
United Kingdom
Italy
Spain
o Asia-Pacific
China
Japan
India
South Korea
Australia
o Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
o South America
Brazil
Argentina
Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global genomic medicine market.

Available Customizations:

With the given market data, we offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).
Read the full report: https://www.reportlinker.com/p06177434/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting